Trial Profile
Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Osteosarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 31 Jul 2012 Actual patient number changed from 36 to 38 as reported by ClinicalTrials.gov.
- 31 Jul 2012 Actual initiation date changed from 1 Mar 2005 to 1 Jun 2005 as reported by ClinicalTrials.gov.
- 09 Sep 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.